AWK vs KNSA · P/E 22, rev $4.65B vs P/E 53, rev $423.2M
American Water Works (AWK) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported KNSA revenue for 2024-12-31 was $423.2M. Net income was -$43.2M. Revenue was up 56.6% from 2023-12-31 to 2024-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the AWK and KNSA stock pages for the full models.
Not investment advice.